Nonhealing Diabetic Foot Ulcers Treated With Standard of Care (SOC) Alone or Standard of Care and Amnion-Intermediate-Chorion (AIC)
Part of paid clinical trials in Santa Rosa, California.
- Sponsor
- Cellution Biologics
- Study ID
- NCT07014176
- Phase
- PHASE4
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Amnion-Intermediate-Chorion — OTHERDehydrated human placental multilayer allograft from derived donated human tissue. AIC contains amnion and chorion layers as well as basement membrane and trophoblast.
- Standard of Care (SOC) — PROCEDUREStandard of care is to establish a clean, healthy wound bed and optimize the wound environment to have the best chance of healing the wound. This is achieved through wound cleansing, debridement, offloading and moisture balance.
Study Details
The purpose of this study is to determine how well our dHPT (Dehydrated Human Placental Tissue) Product and Standard of Care work when compared to Standard of Care alone in achieving complete closure of diabetic foot.
Key Dates
- Start date
- Jul 3, 2025
- Status verified
- Oct 2025
- Primary completion
- Jun 30, 2026
- Completion
- Oct 31, 2026
Study Design
- Enrollment
- 120 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Standard of CareBeginning at the screening visit, participants will receive weekly treatment with standard of care (cleaning, debridement, ulcer moisture balance, and offloading) until ulcer closure, or a maximum of 12 weeks, whichever occurs first.
- Experimental: AIC and Standard of CareParticipants with a diabetic foot ulcer (DFU) will receive treatment with an Amnion-Intermediate-Chorion (AIC) sheet product, a dehydrated multilayer human placental tissue derived from donated human tissue, and weekly treatment with standard of care (cleaning, debridement, ulcer moisture balance, and offloading) until ulcer closure, or a maximum of 12 weeks, whichever occurs first.
Primary Outcome Measure
Percentage of ulcers with complete wound closure [ Time Frame: 1-12 weeks ]
Central Contacts
- Bryanna Finstein, BS6035574660
- Cellution Research6035574660
Locations (8)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| 005 | Santa Rosa | California | 95403 | |
| 001 | Jacksonville | Florida | 32216 | |
| 003 | Chicago | Illinois | 60611 | Sayeed, MD (PRINCIPAL_INVESTIGATOR) |
| 007 | Mooresville | North Carolina | 28117 | |
| 002 | Rocky Mount | North Carolina | 27804 | |
| 008 | Allentown | Pennsylvania | 18104 | |
| 004 | Philadelphia | Pennsylvania | 19146 | |
| 006 | Hilton Head Island | South Carolina | 29926 | - |
Find similar trials in Santa Rosa, CA
Related Studies
- Smart Boot Use to Measure Offloading AdherencePHASE2 · Recruiting · University of Southern California · Downey, California
- Real World Evidence with the Debritom+ TM Novel Micro Water Jet Technology At a Single Wound CenterRecruiting · Medaxis, LLC · Bradenton, Florida
- A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.Recruiting · Molnlycke Health Care AB · Castro Valley, California
- Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot UlcersRecruiting · Piomic Medical · Mesa, Arizona